Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Renibus Therapeutics, Inc.

Clinical trials sponsored by Renibus Therapeutics, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug aims to help kidney patients fight acid and stay strong Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Terminated 1

Can a single infusion protect the heart and kidneys after surgery?

Disease control Stopped early

This extension study follows people who completed an earlier trial (REN-007) to see how they fare for up to 12 months after cardiac surgery. Researchers will track quality of life and serious complications like kidney disease, heart attack, stroke, and hospital readmissions. Part…

Sponsor: Renibus Therapeutics, Inc. • Aim: Disease control

Last updated Aug 15, 2026 00:00 UTC